Clinical Trials on High-risk Myelodysplastic Syndrome in Switzerland
Total 54 results
-
Swiss Group for Clinical Cancer ResearchCompletedMyelodysplastic SyndromesSwitzerland
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
University Hospital, Basel, SwitzerlandRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesSwitzerland
-
University of ZurichUnknown
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
-
GWT-TUD GmbHCelgeneRecruitingMyelodysplastic SyndromesAustria, Germany, Spain, Switzerland
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | AnemiaBelgium, Switzerland, Czech Republic, Portugal, Austria, Netherlands, Slovakia
-
European Working Group of MDS in ChildhoodUnknownMyelodysplastic Syndromes | LeukemiaGermany, Austria, Switzerland, Czech Republic, Netherlands, Denmark, Belgium, Italy, Poland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Switzerland
-
European Organisation for Research and Treatment...WithdrawnMyelodysplastic SyndromesFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
European Organisation for Research and Treatment...CompletedMyelodysplastic Syndromes | LeukemiaBelgium, Switzerland, Netherlands, Germany
-
Balgrist University HospitalIndustry (Schülke & Mayr AG, Switzerland and Germany)RecruitingElective Surgery | High Risk | Prevention of Surgical Site Infections | Randomized-controlled TrialSwitzerland
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsBelgium, Netherlands, Germany, Italy, United Kingdom, Austria, Czech Republic, Croatia, Turkey, Switzerland
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteSwitzerland, France
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
Molecular Partners AGRecruitingLeukemia | Acute | Relapsed | MyeloidNetherlands, France, Lithuania, Switzerland
-
Rene KahnCompletedUltra High Risk for PsychosisSpain, Austria, Germany, Israel, Italy, Netherlands, Norway, Switzerland, United Kingdom
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
CelgeneCompletedLeukemia, Myelomonocytic, Juvenile | Myelodysplastic SyndromeSpain, Germany, Italy, United Kingdom, Belgium, France, Denmark, Netherlands, Sweden, Switzerland, Austria, Czechia, Ireland
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
Gilead SciencesTerminatedMyelodysplastic SyndromesUnited States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
-
Novartis PharmaceuticalsCompletedMyelodysplastic SyndromesChina, Hong Kong, Switzerland, United Kingdom, Italy, Thailand, Bulgaria, Greece, Russian Federation, Canada, Mexico, Australia, Denmark, Malaysia, New Zealand, United States
-
AmgenCompletedMDSGermany, Italy, Belgium, Czechia, Switzerland, France, Austria, Greece, Spain
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Active, not recruitingMyelodysplastic SyndromesUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turke... and more
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
Janssen Research & Development, LLCargenxWithdrawnMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited Kingdom, Switzerland, Italy, Germany, France, Spain, Australia, Turkey, Brazil, Russian Federation, Saudi Arabia
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | LeukemiaSwitzerland, Netherlands, France, Belgium, Germany, Sweden, Croatia, Czech Republic, Italy
-
Christian BalmerTerminatedSudden Cardiac Death | Wolff-Parkinson-White Syndrome | Risk StratificationSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedLymphoma | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neuroblastoma | RhabdomyosarcomaSwitzerland, Germany
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaBelgium, Hungary, Spain, Germany, Canada, Switzerland, Thailand, Korea, Republic of, United Kingdom, Italy, Austria, Sweden, France, United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicChina, Czechia, Japan, Saudi Arabia, Taiwan, Turkey, Germany, Spain, Netherlands, Italy, Singapore, Australia, Austria, France, United Kingdom, Korea, Republic of, Thailand, Israel, Belgium, Canada, Switzerland, Lithuania, Russian Federation and more
-
University Hospital FreiburgCompletedMyelodysplastic Syndromes | Fanconi Anemia | Dyskeratosis Congenita | Pearson Marrow-pancreas Syndrome | Shwachman-diamond SyndromeSpain, Germany, Switzerland, Austria, Netherlands, Italy, Czech Republic, Belgium, Denmark, Ireland
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
European Organisation for Research and Treatment...TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Neutropenia | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Fever, Sweats, and Hot Flashes | Myelodysplastic/Myeloproliferative NeoplasmsFrance, Switzerland, Belgium, Germany, Italy, Israel, Slovakia, Turkey
-
University Hospital, Basel, SwitzerlandNovartis; ProPatient foundation of the University Hospital BaselCompletedAplastic Anemia | Paroxysmal Nocturnal HemoglobinuriaSwitzerland
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Amsterdam UMCRecruitingBarrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaNetherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownBarrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaFrance, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
-
Omeros CorporationRecruitingParoxysmal Nocturnal HemoglobinuriaSwitzerland, Germany, Ukraine, United Kingdom
-
Omeros CorporationRecruitingParoxysmal Nocturnal HemoglobinuriaGermany, Greece, Switzerland, United Kingdom
-
European Organisation for Research and Treatment...CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Fever, Sweats, and Hot Flashes | Bone Marrow SuppressionSwitzerland, United States, Canada, United Kingdom, Belgium, Israel, Slovakia, Finland, Germany, France, Turkey, Czech Republic, Greece
-
Ablynx, a Sanofi companyCompletedUnstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia
-
Alexion PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria | PNHAustralia, France, United Kingdom, Belgium, Germany, Netherlands, Ireland, United States, Switzerland, Italy
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece